| Home | E-Submission | Sitemap | Contact Us |  
J Korean Soc Ther Radiol Oncol > Volume 29(2); 2011 > Article
The Journal of the Korean Society for Therapeutic Radiology and Oncology 2011;29(2): 99-106. doi: https://doi.org/10.3857/jkstro.2011.29.2.99
Quality Assurance of Intensity Modulated Radiation Therapy: Site-Specific Results of Eulji University Hospital
Sung Jin Kim, Mi Jo Lee, Seon Min Youn
Department of Radiation Oncology, Eulji University Hospital, Eulji University College of Medicine, Daejeon, Korea. smyoun@eulji.ac.kr
To analyze our quality assurance (QA) data for intensity modulated radiation therapy (IMRT) according to treatment site and to possibly improve QA for IMRT in Hospital.
We performed QA on 50 patients (head and neck, 28 patients; Breast, 14 patients; Pelvis, 8 patients) for IMRT. The calculated dose from RTP was compared with the measured value film, gamma index, and ionization chamber for dose measurement in each case.
The point dose measurement results in 45 of 50 patients showed good agreement with the calculation dose (+/-3%). The largest error measured thus far has been 3.60%, with a mean of only -0.17% (SD, 2.25%). Each treatment site showed an error rate of -0.13% (SD, 1.93%) for head and neck cases, -0.26% (SD, 2.79%) for breast cases, and -0.24% (SD, 2.44%) for pelvis cases. The gamma index verified with the error rate of head and neck cases (6%), breast (10%), and pelvis (6%), which corresponded to a tolerance of 3 mm (3% for the head and neck, 2%, for the breast 1% for the pelvis, and 0% in the region where the isodose curve was greater than 90%.
We recognize the cause of errors for each treatment site of IMRT QA and so we maximize our efforts to reduce error and increase accuracy.
Key Words: Intensity-modulated radiation therapy, Quality assurance, Error rate
Editorial Office
Department of Radiation Oncology,
Samsung Medical Center, Sungkyunkwan University School of Medicine,
81 Irwon-Ro, Gangnam-gu, Seoul 06351, Korea
TEL: +82-2-3410-2612  E-mail: rojeditor@gmail.com
Copyright © The Korean Society for Radiation Oncology. All rights reserved.                      developed in m2community
Close layer
prev next